ALPMY
ASTELLAS PHARMA/ADR

321
Mkt Cap
$26.26B
Volume
131,188.00
52W High
$16.95
52W Low
$8.37
PE Ratio
12.19
ALPMY Fundamentals
Price
$14.88
Prev Close
$14.66
Open
$14.38
50D MA
$14.95
Beta
0.25
Avg. Volume
189,332.89
EPS (Annual)
$0.1859
P/B
2.33
Rev/Employee
$919,438.95
$22,390.70
Loading...
Loading...

About

Astellas Pharma, Inc. engages in the research, development, manufacture, import, and export of pharmaceutical products. Its products: XTANDI, PADCEV, XOSPATA, VYLOY, VEOZAH, IZERVAY, EVRENZO, BETANIS and PROGRAF. The company was founded by Kenji Yamanouchi in April 1923 and is headquartered in Tokyo, Japan.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
13,643

Frequently Asked Questions

What is Market Cap of Astellas Pharma Inc. - ADR?
What is the 52-week high for Astellas Pharma Inc. - ADR?
What is the 52-week low for Astellas Pharma Inc. - ADR?
What is Astellas Pharma Inc. - ADR stock price today?
What was Astellas Pharma Inc. - ADR stock price yesterday?
What is the PE ratio of Astellas Pharma Inc. - ADR?
What is the Price-to-Book ratio of Astellas Pharma Inc. - ADR?
What is the 50-day moving average of Astellas Pharma Inc. - ADR?
How many employees does Astellas Pharma Inc. - ADR have?

Latest ALPMY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.